NCT04928976View on ClinicalTrials.gov

Amyloid Prediction in Early Stage Alzheimer's Disease Through Speech Phenotyping

CompletedOBSERVATIONAL
Enrollment

67

Participants

Timeline

Start Date

January 22, 2021

Primary Completion Date

July 30, 2021

Study Completion Date

July 30, 2021

Conditions
Alzheimer DiseasePreclinical Alzheimer's DiseaseProdromal Alzheimer's DiseaseAlzheimer's Disease (Incl Subtypes)Mild Cognitive Impairment
Trial Locations (1)

92705

Syrentis Clinical Research, Santa Ana

All Listed Sponsors
lead

Novoic Limited

INDUSTRY

NCT04928976 - Amyloid Prediction in Early Stage Alzheimer's Disease Through Speech Phenotyping | Biotech Hunter | Biotech Hunter